Advertisement

Prescription drug abuse: Problem, policies, and implications

Published:December 14, 2012DOI:https://doi.org/10.1016/j.outlook.2012.06.009

      Abstract

      This article provides an overview on prescription drug abuse and highlights a number of related legislative bills introduced during the 112th Congress in response to this growing epidemic. Prescription drug abuse has emerged as the nation’s fastest growing drug problem. Although prescription drugs have been used effectively and appropriately for decades, deaths from prescription pain medicine in particular have reached epidemic proportions. Bills related to prescription drug abuse introduced during the 112th Congress focus on strengthening provider and consumer education, tracking and monitoring prescription drug abuse, improving data collection on drug overdose fatalities, combating fraud and abuse in Medicare and Medicaid programs, reclassifying drugs to make them more difficult to prescribe and obtain, and enforcing stricter penalties for individuals who operate scam pain clinics and sell pain pills illegitimately. This article underscores the importance of a multifaceted approach to combating prescription drug abuse and concludes with implications for nursing.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Nursing Outlook
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Birnbaum H.G.
        • White A.G.
        • Schiller M.
        • Waldman T.
        • Cleveland J.M.
        • Roland C.L.
        Societal costs of prescription opioid abuse, dependence, and misuse in the United States.
        Pain Medicine. 2011; 12: 657-667
      1. Centers for Disease Control and Prevention. (2011a, November). Prescription painkiller overdoses in the US. Retrieved from http://www.cdc.gov/vitalsigns/PainkillerOverdoses.

      2. Centers for Disease Control and Prevention. (2011b, November). Policy impact: Prescription painkiller overdoses. Retrieved from http://www.cdc.gov/HomeandRecreationalSafety/rxbrief/.

      3. Drug Enforcement Administration. (2011, April). Over 47,000 sites join DEA nationwide effort to take back prescription drugs on April 30. Retrieved from http://www.nationaltakebackday.com.

      4. Fraudulent Prescription Prevention Act of 2011, H.R. 1266, 112th Cong. (2011).

        • Gerhardt A.M.
        Identifying the drug seeker: The Advanced Practice Nurses’ role in managing prescription drug abuse.
        Journal of the American Academy of Nurse Practitioners. 2004; 16: 239-243
        • Government Accounting Office
        Methadone Associated Overdose Deaths: Factors. Contributing to Increased Deaths and Efforts to Prevent Them.
        (GAO-09-341) U.S. Government Printing Office, Washington, DC2009
        • Hernandez S.H.
        • Nelson L.S.
        Prescription drug abuse: Insight into the epidemic.
        Clinical Pharmacology and Therapeutics. 2010; 88: 307-317
        • Institute of Medicine
        Relieving pain in America: A blueprint for transforming prevention, care, education and research.
        The National Academies Press, Washington, DC2011
        • Jenna A.B.
        • Goldman D.P.
        Growing internet use may help explain the rise in prescription drug abuse in the United States.
        Health Affairs. 2011; 30: 1-8
        • Johnston L.D.
        • O’Malley P.M.
        • Bachman J.G.
        • Schulenberg J.E.
        Monitoring the future national results on adolescent drug use: Overview of key findings, 2010.
        Institute for Social Research, the University of Michigan, Ann Arbor2011
      5. Medicare and Medicaid FAST Act, S. 1251,112th Cong. (2011).

      6. Medicare and Medicaid FAST Act, H.R. 3339,112th Cong. (2011).

      7. National All Schedules Prescription Electronic Reporting (NASPER) Reauthorization Act of 2011, H.R. 866, 112th Cong. (2011).

      8. National Institute of Drug Abuse. (2011). Prescription drug abuse and addiction. Retrieved from http://drugabuse.gov/PDF/RRPrescription.pdf.

      9. Office of National Drug Control Policy (2011). Epidemic: Responding to America’s Prescription Drug Abuse Crisis. Retrieved from http://www.whitehouse.gov/sites/default/files/ondcp/policy-and-research/rx_abuse_plan.pdf.

      10. Pill Mill Crackdown Act of 2011, H.R. 1065,112th Cong. (2011).

        • Practitioner Healthcare Foundation
        Managing chronic pain with opioids: A call for change.
        Author, Bellevue, WA2010
      11. Prescription Drug Abuse and Treatment Act of 2011, S.507, 112th Cong. (2011).

      12. Prescription Drug Abuse and Treatment Act of 2011, H.R. 1925, 112th Cong. (2011).

      13. Ryan Creedon Act of 2011, H.R. 2119, 112th Cong. (2011).

      14. Secure and Responsible Drug Disposal Act of 2010, Pub. L. No.111-273, 124 Stat. 2858. STOP ACT, S. 882, 112th Cong. (2011).

      15. Stop Oxy Abuse Act of 2011, H.R. 1316,112th Cong. (2011).

      16. Substance Abuse and Mental Health Services Administration. (2011). Results from the 2010 National Survey on Drug Use and Health. Retrieved from http://oas.samhsa.gov/NSDUH/2k10NSDUH/2k10Results.pdf.

      17. United States Department of Justice. (2011). State Drug Monitoring Programs. Retrieved from http://www.deadiversion.usdoj.gov/faq/rx_monitor.htm.

        • Zee A.V.
        The promotion and marketing of OxyContin: Commercial triumph, public health tragedy.
        American Journal of Public Health. 2009; 99: 221-227